ORCID as entered in ROS

Select Publications
2014, 'Luc Delannoy, director del Instituto de Neuroartes, Tijuana, México', Revista Chilena de Salud Pública, 18, pp. 95 - 95, http://dx.doi.org/10.5354/0719-5281.2014.30761
,2014, 'Luc Delannoy, director del Instituto de Neuroartes, Tijuana, México', Revista Chilena de Salud Pública, 18, http://dx.doi.org/10.5354/0717-3652.2014.30761
,2014, 'Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?', Frontiers in Genetics, 5, http://dx.doi.org/10.3389/fgene.2014.00391
,2011, 'Post-transplant lymphoproliferative disease (PTLD): Pharmacological, virological and other determinants', Pharmacological Research, 63, pp. 1 - 7, http://dx.doi.org/10.1016/j.phrs.2010.10.016
,1982, 'VISUAL LOCALIZATION DURING EYE TRACKING ON STEADY BACKGROUND AND DURING STEADY FIXATION ON MOVING BACKGROUND', BIOLOGICAL CYBERNETICS, 42, pp. 215 - 219
,2020, 'The FcγRIIIa-158 VV Genotype Increased the Risk of Post-Transplant Lymphoproliferative Disorder in T-Cell Depleted Kidney Transplant Recipients', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY, ELECTR NETWORK, pp. 435 - 435, presented at American Transplant Congress (ATC), ELECTR NETWORK, 30 May 2020 - 01 June 2020
,2015, 'Genetic polymorphisms of the calcineurin pathway and their implication in renal transplant patient outcomes', in FUNDAMENTAL & CLINICAL PHARMACOLOGY, WILEY-BLACKWELL, pp. 11 - 11
,2014, 'Pharmacogenetics of the calcineurin pathway and the risk of acute rejection in kidney transplant patients', in FUNDAMENTAL & CLINICAL PHARMACOLOGY, WILEY-BLACKWELL, pp. 41 - 41
,2013, 'LMP1-CD40 Mouse Model of Lymphoma: A New Model to Evaluate the Lymphomagenesis Potential of Immunosuppressants', in THERAPEUTIC DRUG MONITORING, LIPPINCOTT WILLIAMS & WILKINS, UT, Salt Lake City, pp. 694 - 695, presented at 13th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, UT, Salt Lake City, 22 September 2013 - 26 September 2013
,2011, 'Pharmacological & pharmacogenetic factors in post-transplant lymphoproliferative disease: feasibility of matching in a case-control study', in THERAPEUTIC DRUG MONITORING, LIPPINCOTT WILLIAMS & WILKINS, GERMANY, Stuttgart, pp. 509 - 510, presented at 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, GERMANY, Stuttgart, 02 October 2011 - 06 October 2011
,2011, 'Pharmacological determinants of post-transplant lymphoproliferative disease (PTLD): feasibility of a large case-control study', in FUNDAMENTAL & CLINICAL PHARMACOLOGY, WILEY-BLACKWELL, pp. 65 - 66
,2004, 'Rare genetic aberrations in adult CD10+B-cell acute lymphoblastic leukemia (B-ALL)', in GENES AND IMMUNITY, NATURE PUBLISHING GROUP, BULGARIA, Sofia, pp. S48 - S48, presented at 18th European Histocompatibility Conference, BULGARIA, Sofia, 08 May 2004 - 11 May 2004
,1984, 'COMPARATIVE QUANTITATIVE INVESTIGATIONS OF A1, B AND RH0(D) ERYTHROCYTE ANTIGENS IN NEWBORNS AND ADULTS', in BIOMEDICA BIOCHIMICA ACTA, AKADEMIE VERLAG GMBH, pp. S59 - S60
,2023, 'It Cuts Both Ways: Single-Center Retrospective Review Describing Three-Way Interaction Between Flucloxadllin, Voriconazole and Tacrolimus', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, CO, Denver, Vol. 42, pp. S500 - S500, presented at 43rd Annual Meeting of International Society for Heart and Lung Transplantation (ISHLT), CO, Denver, 19 April 2023 - 22 April 2023, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000992480601388&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2024, Geographical and Gender Diversity in Cochrane and non-Cochrane Reviews Authorship: A Meta-Research Study, http://dx.doi.org/10.31222/osf.io/bvej5
,2024, Geographical and Gender Diversity in Cochrane and non-Cochrane Reviews Authorship: A Meta-Research Study, http://dx.doi.org/10.31222/osf.io/bvej5_v1
,2024, Geographical and Gender Diversity in Cochrane and non-Cochrane Reviews Authorship: A Meta-Research Study, http://dx.doi.org/10.1101/2024.03.23.24304672
,2022, The Evidence Synthesis and Meta-Analysis in R Conference (ESMARConf): levelling the playing field of conference accessibility and equitability, http://dx.doi.org/10.21203/rs.3.rs-1506276/v1
,